Home/Filings/4/0001179110-22-000962
4//SEC Filing

OLER ABRAHAM N. 4

Accession 0001179110-22-000962

CIK 0001130598other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:38 PM ET

Size

7.8 KB

Accession

0001179110-22-000962

Insider Transaction Report

Form 4
Period: 2022-02-07
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Award

    Stock Option (right to purchase)

    2022-02-07+54,05054,050 total
    Exercise: $1.82Exp: 2032-02-07Common stock (54,050 underlying)
  • Award

    Restricted Stock Units

    2022-02-07+17,63317,633 total
    Common stock (17,633 underlying)
Footnotes (3)
  • [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
  • [F2]These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
  • [F3]Each restricted stock unit is convertible into one share of common stock.

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1
  • filerCIK 0001557372

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:38 PM ET
Size
7.8 KB